--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.753B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Salesforce
CRM
Adobe
ADBE
Oracle
ORCL
Amazon
AMZN
Broadcom
AVGO
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 746.130
- -3.440-0.46%
Trading Dec 4 10:04 ET
81.99BMarket Cap18.45P/E (TTM)
751.517High745.010Low53.58KVolume748.560Open749.570Pre Close40.09MTurnover0.05%Turnover Ratio21.46P/E (Static)109.89MShares1211.20052wk High2.80P/B78.65BFloat Cap735.95552wk Low--Dividend TTM105.41MShs Float1211.200Historical High--Div YieldTTM0.87%Amplitude4.610Historical Low748.327Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Regeneron Pharmaceuticals Q3 2024 Earnings Date
Currency：USDOct 31, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 3.67B | 3.72B | +53.88M |
| Beat Est. | +9.04% | +10.65% | +1.47% |
| EPS | 9.58 | 11.54 | +1.96 |
| Beat Est. | +7.81% | +29.81% | +20.41% |
Analyst Rating
Nov 30, 2024
Regeneron Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Regeneron Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
